8-K: Silgan Reports Q3 2025 Results, Revises Full-Year EPS Down

Silgan Holdings Inc. announced third quarter 2025 net sales of $2.01 billion and net income of $113.3 million, while revising its full-year adjusted EPS guidance downward due to anticipated lower volumes and higher expenses.

Summary

• Net sales for the third quarter of 2025 were $2.01 billion, an increase of 15% compared to $1.75 billion in Q3 2024.
• Net income for Q3 2025 was $113.3 million, or $1.06 per diluted share, up from $100.1 million, or $0.93 per diluted share, in Q3 2024.
• Adjusted net income per diluted share for Q3 2025 increased 1% to $1.22, compared to $1.21 in the prior year period.
• Achieved 11% Adjusted EBITDA growth in the third quarter.
• The Dispensing and Specialty Closures segment delivered record Adjusted EBIT growth of 19%, reaching $113.5 million.
• The Metal Containers business saw mid-single digit volume growth, including a double-digit increase in pet food products.
• The Custom Containers segment achieved record third quarter Adjusted EBIT of $23.1 million, with 4% volume improvement on a comparable basis.
• Returned over $120 million to shareholders year-to-date through share repurchases and dividends.
• Confirmed the 2025 free cash flow estimate of $430 million, a 10% increase over 2024.
• Revised the full-year 2025 adjusted net income per diluted share estimate downward from a range of $3.85-$4.05 to $3.66-$3.76.
• Provided a Q4 2025 adjusted net income per diluted share estimate in the range of $0.62-$0.72, compared to $0.85 in Q4 2024.
• Increased the 2025 estimate for interest and other debt expense from approximately $185 million to $190 million.
• Increased the adjusted tax rate for 2025 from 24% to approximately 24.5%.

Sentiment

Score: 5

Explanation: While Q3 results showed strong performance in key segments and strategic growth initiatives, the downward revision of full-year adjusted EPS guidance and a significantly lower Q4 outlook due to volume softness in certain markets and increased expenses indicate a mixed sentiment. The company acknowledges a more challenging market backdrop than anticipated.

Positives

• Achieved sixth consecutive quarter of record Dispensing and Specialty Closures adjusted EBIT.
• Realized mid-teen percentage organic growth in dispensing volumes for fragrance markets.
• Delivered double-digit growth in metal containers for pet food markets.
• Returned over $120 million to shareholders year-to-date in share repurchases and dividends.
• Dispensing and Specialty Closures segment delivered 19% Adjusted EBIT growth, driven by the Weener acquisition and high-value fragrance dispensing products.
• Metal Containers business performed well with mid-single digit volume growth.
• Custom Containers achieved record third quarter Adjusted EBIT by delivering value and executing cost reduction plans, resulting in 4% volume improvement on a comparable basis.
• Delivered 10% adjusted EPS growth year-to-date.
• Confirmed 2025 free cash flow estimate of $430 million, a 10% increase compared to $391.3 million in 2024.

Negatives

• Revised full-year 2025 adjusted net income per diluted share estimate downward from a range of $3.85-$4.05 to $3.66-$3.76.
• Anticipates lower volumes for certain products for personal care and home care markets in North America in Q4 2025.
• Expects a higher than anticipated tax rate in 2025, increasing to approximately 24.5% from 24%.
• Anticipates incremental interest expense related to the recent euro bond issuance, increasing the 2025 estimate to $190 million from $185 million.
• Fourth quarter 2025 adjusted net income per diluted share is expected to be $0.62-$0.72, significantly lower than $0.85 in Q4 2024.
• Experienced a 5% decline in closure volumes for North American beverage markets in Q3 2025.
• Metal Containers Adjusted EBIT decreased by $1.3 million in Q3 2025 due to less favorable price/cost including mix.
• The market backdrop in 2025 has been more challenging than anticipated entering the year.

Risks

• Lower customer volume forecasts for certain products in North American personal care and home care markets in the fourth quarter, potentially leading to under-absorbed costs from production downtime and inventory reductions.
• Higher income tax expense due to changes in the geographic mix of profit.
• Increased interest expense from higher borrowings related to the Weener acquisition and the recent unsecured euro notes issuance.
• Dynamic customer and end market conditions impacting business resilience.
• General uncertainties and risks described in the Company's Annual Report on Form 10-K for 2024 and other filings with the Securities and Exchange Commission.

Future Outlook

The company revised its full-year 2025 adjusted net income per diluted share estimate downward to a range of $3.66 to $3.76, citing lower volume expectations for North American personal care and home care markets in the fourth quarter, leading to under-absorbed costs, as well as higher anticipated tax and interest expenses. Despite these headwinds, the company confirmed its 2025 free cash flow estimate of $430 million and expects earnings growth in 2026 and beyond, driven by continued strong organic growth in fragrance and pet care markets and expansion of its high-value dispensing business.

Management Comments

• "Our third quarter results continued to exhibit the success of our strategic growth initiatives, the resilience of our business through dynamic customer and end market conditions and the benefits of our disciplined capital deployment model, as we delivered 11% Adjusted EBITDA growth in the quarter." Adam Greenlee, President and CEO.
• "Our third quarter performance was consistent with our expectations, with continued strong organic growth in dispensing products and metal containers for pet food markets, which was partially offset by the isolated headwinds that we identified entering the quarter." Adam Greenlee, President and CEO.
• "Our Dispensing and Specialty Closures segment delivered another quarter of record performance with Adjusted EBIT growth of 19% driven by the successful integration of the Weener acquisition and continued growth in high value fragrance dispensing products, and our teams successfully navigated the anticipated impact of lower closure volumes for beverage products in North America." Adam Greenlee, President and CEO.
• "Our business continues to perform well and has delivered 10% adjusted EPS growth year to date, as the evolution of our portfolio has continued to deliver organic growth and margin enhancement." Adam Greenlee, President and CEO.
• "We continue to see significant opportunity to expand our high value, high growth dispensing business both organically and through value and earnings accretive capital deployment and are seeing incremental organic growth opportunities as a result of the Weener acquisition." Adam Greenlee, President and CEO.
• "While the developments in the market backdrop in 2025 have been more challenging than we anticipated entering the year, one of the hallmarks of Silgan is our resilient performance in the face of challenging market conditions." Adam Greenlee, President and CEO.
• "We continue to believe our portfolio of consumer staple products remains well positioned to outpace growth in our end markets, and our Company is poised to deliver earnings growth again in 2026 and beyond." Adam Greenlee, President and CEO.

Industry Context

Silgan operates in the rigid packaging solutions industry, supplying essential consumer goods products. The company's performance reflects broader trends in consumer staples, with strong demand in fragrance and pet food markets offsetting softer demand in North American beverage, personal care, and home care segments. The successful integration of the Weener acquisition highlights the ongoing consolidation and strategic M&A activity within the packaging sector to expand high-value product offerings and geographic reach.

Stakeholder Impact

• Shareholders: Positive impact from over $120 million returned year-to-date in share repurchases and dividends. Negative impact from revised downward full-year EPS guidance and lower Q4 EPS expectations.
• Customers: Mixed impact, with strong partnerships and expanded capabilities, but also lower volumes for certain beverage, personal care, and home care products.
• Employees: Potential impact from rationalization charges and production downtime related to inventory reductions.
• Creditors: Increased interest expense due to higher borrowings and recent euro bond issuance.

Next Steps

• Continue to expand high value, high growth dispensing business organically and through value and earnings accretive capital deployment.
• Manage inventory levels into year-end due to lower customer volume forecasts in certain markets.
• Deliver earnings growth in 2026 and beyond.
• Hold a conference call on October 29, 2025, to discuss Q3 results.

Key Dates

Recommendation

While Silgan demonstrated strong Q3 performance in key growth areas like fragrance and pet food packaging, and continues to return capital to shareholders, the significant downward revision of full-year adjusted EPS guidance and a weaker Q4 outlook due to market headwinds in North American personal care and home care, coupled with higher tax and interest expenses, introduce uncertainty. The company's resilience and long-term growth prospects in consumer staples are positive, but the near-term challenges warrant a cautious 'hold' stance until there's clearer visibility on market stabilization and the effectiveness of cost management strategies.

Keywords

Silgan Holdings, SLGN, Rigid Packaging, Dispensing Closures, Specialty Closures, Metal Containers, Custom Containers, Q3 2025 Earnings, Financial Results, Adjusted EPS, Free Cash Flow, Weener Acquisition, Fragrance Packaging, Pet Food Packaging, Consumer Goods Packaging, SEC Filing